JP2023535225A5 - - Google Patents

Info

Publication number
JP2023535225A5
JP2023535225A5 JP2023505388A JP2023505388A JP2023535225A5 JP 2023535225 A5 JP2023535225 A5 JP 2023535225A5 JP 2023505388 A JP2023505388 A JP 2023505388A JP 2023505388 A JP2023505388 A JP 2023505388A JP 2023535225 A5 JP2023535225 A5 JP 2023535225A5
Authority
JP
Japan
Prior art keywords
cancer
lipid nanoparticles
sequence
guanosine
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023505388A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023535225A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/043214 external-priority patent/WO2022020811A1/en
Publication of JP2023535225A publication Critical patent/JP2023535225A/ja
Publication of JP2023535225A5 publication Critical patent/JP2023535225A5/ja
Pending legal-status Critical Current

Links

JP2023505388A 2020-07-24 2021-07-26 改変ヌクレオチドを含む脂質ナノ粒子 Pending JP2023535225A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063056382P 2020-07-24 2020-07-24
US63/056,382 2020-07-24
PCT/US2021/043214 WO2022020811A1 (en) 2020-07-24 2021-07-26 Lipidnanoparticle comprising modified nucleotides

Publications (2)

Publication Number Publication Date
JP2023535225A JP2023535225A (ja) 2023-08-16
JP2023535225A5 true JP2023535225A5 (https=) 2024-07-31

Family

ID=77412342

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023505388A Pending JP2023535225A (ja) 2020-07-24 2021-07-26 改変ヌクレオチドを含む脂質ナノ粒子

Country Status (5)

Country Link
US (1) US20230295257A1 (https=)
EP (1) EP4185274A1 (https=)
JP (1) JP2023535225A (https=)
CN (1) CN116710079A (https=)
WO (1) WO2022020811A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3018046A1 (en) * 2011-12-16 2013-06-20 Moderna Therapeutics, Inc. Modified nucleoside, nucleotide, and nucleic acid compositions
CN113966221B (zh) * 2019-03-08 2026-03-31 麻省理工学院 合成溶瘤lnp复制子rna和用于癌症免疫治疗的用途
CN119317430A (zh) * 2022-04-26 2025-01-14 斯特兰德生物科技公司 包含委内瑞拉马脑炎(vee)复制子的脂质纳米颗粒及其用途
AU2024279278A1 (en) 2023-05-31 2025-12-18 Capstan Therapeutics, Inc. Lipid nanoparticle formulations and compositions

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US4485045A (en) 1981-07-06 1984-11-27 Research Corporation Synthetic phosphatidyl cholines useful in forming liposomes
US4544545A (en) 1983-06-20 1985-10-01 Trustees University Of Massachusetts Liposomes containing modified cholesterol for organ targeting
CA1327358C (en) 1987-11-17 1994-03-01 Morio Fujiu Fluoro cytidine derivatives
US5013556A (en) 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
CA2309535A1 (en) 1997-11-12 1999-05-20 Brigham And Women's Hospital, Inc. The translation enhancer element of the human amyloid precursor protein gene
US7468275B2 (en) 2000-01-28 2008-12-23 The Scripps Research Institute Synthetic internal ribosome entry sites and methods of identifying same
CA2398790A1 (en) 2000-01-28 2001-08-02 The Scripps Research Institute Methods of identifying synthetic transcriptional and translational regulatory elements, and compositions relating to same
EP2447370B1 (en) 2001-09-28 2018-07-18 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. MicroRNA molecules
WO2004041203A2 (en) 2002-11-04 2004-05-21 Xenoport, Inc. Gemcitabine prodrugs, pharmaceutical compositions and uses thereof
US7683036B2 (en) 2003-07-31 2010-03-23 Regulus Therapeutics Inc. Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
EP2479254A1 (en) 2005-08-24 2012-07-25 The Scripps Research Institute Translation enhancer-element dependent vector systems
US7670840B2 (en) 2006-01-05 2010-03-02 The Ohio State University Research Foundation Micro-RNA expression abnormalities of pancreatic, endocrine and acinar tumors
EP1969147B1 (en) 2006-01-05 2014-07-30 The Ohio State University Research Foundation microRNA-based methods for the diagnosis of stomach cancer
EP2522746B1 (en) 2006-03-02 2014-11-12 The Ohio State University Research Foundation MicroRNA expression profile associated with pancreatic cancer
US20090131348A1 (en) 2006-09-19 2009-05-21 Emmanuel Labourier Micrornas differentially expressed in pancreatic diseases and uses thereof
US8252538B2 (en) 2006-11-01 2012-08-28 The Ohio State University MicroRNA expression signature for predicting survival and metastases in hepatocellular carcinoma
WO2008073915A2 (en) 2006-12-08 2008-06-19 Asuragen, Inc. Micrornas differentially expressed in leukemia and uses thereof
WO2008147974A1 (en) 2007-05-23 2008-12-04 University Of South Florida Micro-rnas modulating immunity and inflammation
US20090099034A1 (en) 2007-06-07 2009-04-16 Wisconsin Alumni Research Foundation Reagents and Methods for miRNA Expression Analysis and Identification of Cancer Biomarkers
CN101918594A (zh) 2007-11-30 2010-12-15 俄亥俄州立大学研究基金会 肺癌中外周血中的微rna表达特征谱和靶向
SG10201408162PA (en) 2007-12-11 2015-01-29 Scripps Research Inst Compositions and methods related to mrna translational enhancer elements
EP2260110B1 (en) 2008-02-08 2014-11-12 Asuragen, INC. miRNAs DIFFERENTIALLY EXPRESSED IN LYMPH NODES FROM CANCER PATIENTS
CA2717026A1 (en) 2008-02-28 2009-09-03 The Ohio State University Research Foundation Microrna signatures associated with human chronic lymphocytic leukemia (ccl) and uses thereof
EP2112235A1 (en) 2008-04-24 2009-10-28 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Compositions and methods for microRNA expression profiling of nasopharyngeal carcinoma
PL215513B1 (pl) 2008-06-06 2013-12-31 Univ Warszawski Nowe boranofosforanowe analogi dinukleotydów, ich zastosowanie, czasteczka RNA, sposób otrzymywania RNA oraz sposób otrzymywania peptydów lub bialka
WO2010018563A2 (en) 2008-08-12 2010-02-18 Rosetta Genomics Ltd. Compositions and methods for the prognosis of lymphoma
EP2358902A1 (en) 2008-12-10 2011-08-24 Universität Regensburg Compositions and methods for micro-rna expression profiling of cancer stem cells
EP2427574A2 (en) 2009-05-08 2012-03-14 The Ohio State University Research Foundation Microrna expression profiling and targeting in chronic obstructive pulmonary disease (copd) lung tissue and methods of use thereof
WO2011076142A1 (en) 2009-12-24 2011-06-30 Fudan University Compositions and methods for microrna expession profiling in plasma of colorectal cancer
WO2011076143A1 (en) 2009-12-24 2011-06-30 Fudan University Compositions and methods for microrna expression profiling of lung cancer
EP2341145A1 (en) 2009-12-30 2011-07-06 febit holding GmbH miRNA fingerprint in the diagnosis of diseases
WO2011094683A2 (en) 2010-01-29 2011-08-04 H. Lee Moffitt Cancer Center And Research Institute, Inc. Method of identifying myelodysplastic syndromes
EP2354246A1 (en) 2010-02-05 2011-08-10 febit holding GmbH miRNA in the diagnosis of ovarian cancer
US20130059015A1 (en) 2010-03-11 2013-03-07 H. Lee Moffitt Cancer Center & Research Institute Human Cancer micro-RNA Expression Profiles Predictive of Chemo-Response
WO2011157294A1 (en) 2010-06-16 2011-12-22 Universita' Degli Studi Di Padova Compositions for use in treating or preventing cancer, breast cancer, lung cancer, ovarian cancer, metastasis, heart failure, cardiac remodelling, dilated cardiomyopathy, autoimmune diseases, or diseases or disorders related thereto
US20130230884A1 (en) 2010-07-16 2013-09-05 John Chaput Methods to Identify Synthetic and Natural RNA Elements that Enhance Protein Translation
KR20120066952A (ko) 2010-12-15 2012-06-25 주식회사 롤팩 7층 구조의 공압출 항균 진공포장 필름 및 그 제조방법
WO2012151212A1 (en) 2011-05-01 2012-11-08 University Of Rochester Multifocal hepatocellular carcinoma microrna expression patterns and uses thereof
EP2705370A2 (en) 2011-05-06 2014-03-12 Xentech Markers for cancer prognosis and therapy and methods of use
DK2732052T3 (en) 2011-07-15 2017-02-20 Leo Pharma As Diagnostic microRNA profiling in cutaneous T cell lymphoma (CTCL)
EP2751292A4 (en) 2011-09-01 2015-05-20 Allegro Diagnostics Corp METHOD AND COMPOSITIONS FOR DETECTING CANCER BASED ON MIRNA EXPRESSION PROFILES
US20140243240A1 (en) 2011-10-26 2014-08-28 Georgetown University microRNA EXPRESSION PROFILING OF THYROID CANCER
WO2013103659A1 (en) 2012-01-04 2013-07-11 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Stabilizing rna by incorporating chain-terminating nucleosides at the 3'-terminus
PL2922554T3 (pl) 2012-11-26 2022-06-20 Modernatx, Inc. Na zmodyfikowany na końcach
EP3053585A1 (en) 2013-12-13 2016-08-10 Moderna Therapeutics, Inc. Alternative nucleic acid molecules and uses thereof
WO2015196118A1 (en) 2014-06-19 2015-12-23 Moderna Therapeutics, Inc. Alternative nucleic acid molecules and uses thereof
ES2880103T3 (es) * 2015-05-21 2021-11-23 Ohio State Innovation Foundation Derivados de benceno-1, 3, 5-tricarboxamida y usos de los mismos
SI3458083T1 (sl) 2016-05-18 2023-03-31 Modernatx, Inc. Polinukleotidi, ki kodirajo interlevkin-12 (IL12) in njihova uporaba
TW202428301A (zh) 2017-02-28 2024-07-16 法商賽諾菲公司 治療性rna
JP7285220B2 (ja) * 2017-05-18 2023-06-01 モデルナティエックス インコーポレイテッド 連結したインターロイキン-12(il12)ポリペプチドをコードするポリヌクレオチドを含む脂質ナノ粒子

Similar Documents

Publication Publication Date Title
JP2023535225A5 (https=)
Liu et al. mRNA cancer vaccines: construction and boosting strategies
CN107849567B (zh) 一种siRNA、含有该siRNA的药物组合物和缀合物及它们的应用
ES3054296T3 (en) Method for reducing immunogenicity of rna
JP2022524391A5 (https=)
JP7139307B2 (ja) Rnaの投与のための配合物
JP2024503000A5 (https=)
JP7808695B2 (ja) タンパク質発現のためのmRNA及びそのための鋳型
JP2021063103A (ja) ポリリボヌクレオチドをコードするatp結合カセットファミリーおよびその製剤
CN116685331A (zh) 用融合相关的小跨膜蛋白配制的蛋白脂质囊泡
JP2024528447A (ja) 非天然型5’非翻訳領域及び3’非翻訳領域、及びその用途
EP3289084B1 (en) siRNA INHIBITION OF HUMAN ANTIGEN R EXPRESSION FOR TREATMENT OF CANCER
Yihunie et al. Recent advances in messenger ribonucleic acid (mRNA) vaccines and their delivery systems: a review
JP2019506862A5 (https=)
Copur Messenger RNA Vaccines: Beckoning of a New Era in Cancer Immunotherapy.
JP5933674B2 (ja) 癌治療用の組合せ製品
KR20250078933A (ko) 단백질 발현을 위한 인공 폴리뉴클레오타이드
Rachamala Translational Advances in Lipid Nanoparticle Drug Delivery Systems for Cancer Therapy: Current Status and Future Horizons
Malhotra et al. SiRNA gene therapy using albumin as a carrier
Lu et al. Novel modifications and delivery modes of cyclic dinucleotides for STING activation in cancer treatment
KR102003239B1 (ko) 경구투여용 간암표적성 siRNA 나노전달체 및 이의 제조방법
JP2025533111A (ja) Rnaコンストラクト及びその使用
WO2025140126A1 (en) Therapeutic ly6k mrna vaccine for cancer
WO2024022263A1 (zh) 脂质化合物和脂质纳米颗粒组合物
WO2024014560A1 (ja) パラスポリン発現ベクター及び医薬組成物